메뉴 건너뛰기




Volumn 18, Issue 1, 2011, Pages 135-142

Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference sera

(22)  Rose, Charles E a   Romero Steiner, Sandra b   Burton, Robert L c   Carlone, George M b   Goldblatt, David d   Nahm, Moon H c   Ashton, Lindsey d   Haston, Mitch d   Ekström, Nina e   Haikala, Raili e   Käyhty, Helena e   Henckaerts, Isabelle f   Durant, Nathalie f   Poolman, Jan T f   Fernsten, Phil g   Yu, Xinhong g   Hu, Branda T g,j   Jansen, Kathrin U g   Blake, Milan h   Simonetti, Elles R i   more..


Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

EID: 78650858088     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00370-10     Document Type: Article
Times cited : (61)

References (25)
  • 1
    • 26944441984 scopus 로고    scopus 로고
    • A fluorescent multivalent opsonophagocytic assay for the measurement of functional antibodies to Streptococcus pneumoniae
    • Bieging, K., et al. 2005. A fluorescent multivalent opsonophagocytic assay for the measurement of functional antibodies to Streptococcus pneumoniae. Clin. Diagn. Lab. Immunol. 12:1238-1242.
    • (2005) Clin. Diagn. Lab. Immunol. , vol.12 , pp. 1238-1242
    • Bieging, K.1
  • 2
    • 78650914798 scopus 로고    scopus 로고
    • Multiplex opsonophagocytosis assay (MOPA): A useful tool for the monitoring of the 7-valent pneumococcal conjugate vaccine
    • Bogaert, D., M. Sluijter, R. de Groot, and P. W. M. Hermans. 2004. Multiplex opsonophagocytosis assay (MOPA): a useful tool for the monitoring of the 7-valent pneumococcal conjugate vaccine. Vaccine 4563:1-7.
    • (2004) Vaccine , vol.4563 , pp. 1-7
    • Bogaert, D.1    Sluijter, M.2    De Groot, R.3    Hermans, P.W.M.4
  • 3
    • 33749498225 scopus 로고    scopus 로고
    • Development and validation of a fourfold multiplex opsonization assay (MOPA4) for pneumococcal antibodies
    • Burton, R. L., and M. H. Nahm. 2006. Development and validation of a fourfold multiplex opsonization assay (MOPA4) for pneumococcal antibodies. Clin. Vaccine Immunol. 13:1004-1009.
    • (2006) Clin. Vaccine Immunol. , vol.13 , pp. 1004-1009
    • Burton, R.L.1    Nahm, M.H.2
  • 4
    • 0031566914 scopus 로고    scopus 로고
    • Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    • Centers for Disease Control and Prevention
    • Centers for Disease Control and Prevention. 1997. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommend. Rep. 46(RR-8):1-24.
    • (1997) MMWR Recommend. Rep. , vol.46 , Issue.RR-8 , pp. 1-24
  • 5
    • 0034612937 scopus 로고    scopus 로고
    • Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    • Centers for Disease Control and Prevention
    • Centers for Disease Control and Prevention. 2000. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommend. Rep. 49(RR-09):1-38.
    • (2000) MMWR Recommend. Rep. , vol.49 , Issue.RR-09 , pp. 1-38
  • 6
    • 77949284625 scopus 로고    scopus 로고
    • Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010
    • Centers for Disease Control and Prevention
    • Centers for Disease Control and Prevention. 2010. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb. Mortal. Wkly. Rep. 59(9):258-261.
    • (2010) MMWR Morb. Mortal. Wkly. Rep. , vol.59 , Issue.9 , pp. 258-261
  • 7
    • 54449088423 scopus 로고    scopus 로고
    • Progress in introduction of pneumococcal conjugate vaccine - Worldwide, 2000-2008
    • Centers for Disease Control and Prevention
    • Centers for Disease Control and Prevention. 2008. Progress in introduction of pneumococcal conjugate vaccine - worldwide, 2000-2008. MMWR Morb. Mortal. Wkly. Rep. 57:1148-1151.
    • (2008) MMWR Morb. Mortal. Wkly. Rep. , vol.57 , pp. 1148-1151
  • 8
    • 12544255422 scopus 로고    scopus 로고
    • Use of HL-60 cell line to measure opsonic apacity of pneumococcal antibodies
    • Fleck, R. A., S. Romero-Steiner, and M. H. Nahm. 2005. Use of HL-60 cell line to measure opsonic apacity of pneumococcal antibodies. Clin. Diagn. Lab. Immunol. 12:19-27.
    • (2005) Clin. Diagn. Lab. Immunol. , vol.12 , pp. 19-27
    • Fleck, R.A.1    Romero-Steiner, S.2    Nahm, M.H.3
  • 9
    • 33847610014 scopus 로고    scopus 로고
    • Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children
    • Henckaerts, I., N. Durant, N. D. De Grave, L. Schuerman, and J. Poolman. 2007. Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children. Vaccine 25:2518-2527.
    • (2007) Vaccine , vol.25 , pp. 2518-2527
    • Henckaerts, I.1    Durant, N.2    De Grave, N.D.3    Schuerman, L.4    Poolman, J.5
  • 10
    • 34347400591 scopus 로고    scopus 로고
    • Set-up and evaluation of interlaboratory studies
    • Heyden, Y., and J. Smeyers-Verbeke. 2007. Set-up and evaluation of interlaboratory studies. J. Chromatogr. A 1158:158-167.
    • (2007) J. Chromatogr. A , vol.1158 , pp. 158-167
    • Heyden, Y.1    Smeyers-Verbeke, J.2
  • 11
    • 22044448196 scopus 로고    scopus 로고
    • Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae
    • Hu, B. T., et al. 2005. Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae. Clin. Diagn. Lab. Immunol. 12:287-295.
    • (2005) Clin. Diagn. Lab. Immunol. , vol.12 , pp. 287-295
    • Hu, B.T.1
  • 12
    • 12444288124 scopus 로고    scopus 로고
    • Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants
    • Jódar, L., et al. 2003. Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants. Vaccine 21:3265-3272.
    • (2003) Vaccine , vol.21 , pp. 3265-3272
    • Jódar, L.1
  • 14
    • 0024521543 scopus 로고
    • A concordance correlation coefficient to evaluate reproducibility
    • Lin, L. I. K. 1989. A concordance correlation coefficient to evaluate reproducibility. Biometrics 45:255-268.
    • (1989) Biometrics , vol.45 , pp. 255-268
    • Lin, L.I.K.1
  • 15
    • 0034212410 scopus 로고    scopus 로고
    • Development of a multispecificity opsonophagocytic killing assay
    • Nahm, M. H., D. E. Briles, and X. Yu. 2000. Development of a multispecificity opsonophagocytic killing assay. Vaccine 18:2768-2771.
    • (2000) Vaccine , vol.18 , pp. 2768-2771
    • Nahm, M.H.1    Briles, D.E.2    Yu, X.3
  • 16
    • 69949111769 scopus 로고    scopus 로고
    • Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: Global estimates
    • O'Brien, K. L., et al. 2009. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374:893-902.
    • (2009) Lancet , vol.374 , pp. 893-902
    • O'Brien, K.L.1
  • 17
    • 71949103062 scopus 로고    scopus 로고
    • Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine
    • Pilishvili, T., et al. 2010. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J. Infect. Dis. 201:32-41.
    • (2010) J. Infect. Dis. , vol.201 , pp. 32-41
    • Pilishvili, T.1
  • 18
    • 13444291999 scopus 로고    scopus 로고
    • Statistical considerations for vaccine immunogenicity trails. Part 2: Non-inferiority and other statistical approaches to vaccine evaluation
    • Plikaytis, B. D., and G. M. Carlone. 2005. Statistical considerations for vaccine immunogenicity trails. Part 2: non-inferiority and other statistical approaches to vaccine evaluation. Vaccine 23:1606-1614.
    • (2005) Vaccine , vol.23 , pp. 1606-1614
    • Plikaytis, B.D.1    Carlone, G.M.2
  • 19
    • 0034091409 scopus 로고    scopus 로고
    • An analytical model applied to a multicenter pneumococcal ELISA study
    • Plikaytis, B. D., et al. 2000. An analytical model applied to a multicenter pneumococcal ELISA study. J. Clin. Microbiol. 38:2043-2050.
    • (2000) J. Clin. Microbiol. , vol.38 , pp. 2043-2050
    • Plikaytis, B.D.1
  • 20
    • 0030801435 scopus 로고    scopus 로고
    • Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells
    • Romero-Steiner, S., et al. 1997. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin. Diagn. Lab. Immunol. 4:415-422.
    • (1997) Clin. Diagn. Lab. Immunol. , vol.4 , pp. 415-422
    • Romero-Steiner, S.1
  • 21
    • 0345257061 scopus 로고    scopus 로고
    • Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae
    • Romero-Steiner, S., et al. 2003. Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae. Clin. Diagn. Lab Immunol. 10:1019-1024.
    • (2003) Clin. Diagn. Lab Immunol. , vol.10 , pp. 1019-1024
    • Romero-Steiner, S.1
  • 22
    • 33644905553 scopus 로고    scopus 로고
    • Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines
    • Romero-Steiner, S., et al. 2006. Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines. Clin. Vaccine Immunol. 13:165-169.
    • (2006) Clin. Vaccine Immunol. , vol.13 , pp. 165-169
    • Romero-Steiner, S.1
  • 23
    • 34247120588 scopus 로고    scopus 로고
    • Estimating the protective concentration of antipneumococcal capsular polysaccharide antibodies
    • Siber, G. R., et al. 2007. Estimating the protective concentration of antipneumococcal capsular polysaccharide antibodies. Vaccine 25:3816-3826.
    • (2007) Vaccine , vol.25 , pp. 3816-3826
    • Siber, G.R.1
  • 24
    • 79955969798 scopus 로고    scopus 로고
    • Recommendations to ensure the quality, safety and efficacy of pneumococcal conjugate vaccines
    • Annex2
    • World Health Organization. 2009. Recommendations to ensure the quality, safety and efficacy of pneumococcal conjugate vaccines. Proposed replacement of TRS 927, Annex2. http://www.who.int/biologicals/areas/vaccines/pneumo/Pneumo- final-23APRIL-2010.pdf.
    • (2009) Proposed Replacement of TRS 927
  • 25
    • 0019544628 scopus 로고
    • The role of complement in the host's defense against Streptococcus pneumoniae
    • Winkelstein, J. A. 1981. The role of complement in the host's defense against Streptococcus pneumoniae. Rev. Infect. Dis. 3:289-298.
    • (1981) Rev. Infect. Dis. , vol.3 , pp. 289-298
    • Winkelstein, J.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.